Major CNV Publication Cites Company Service

OGT is proud to be associated with last week’s Nature publication entitled ‘Origins and functional impact of copy number variation in the human genome’. For the study OGT was chosen as the service provider, having delivered data of exceptional quality during evaluation.

“We are delighted to have been selected for the study due to the high quality of the data generated, and to have contributed to the Nature publication. Subsequently, we have generated in excess of 2 billion CNV data points using the Agilent platform and, most importantly, have achieved a consistently high quality data set,” commented Mike Evans, OGT’s CEO.

At the 59th annual meeting of the American Society of Human Genetics in Honolulu, Hawaii, in October, OGT sponsored the Invited Scientific Session, ‘Impact of Structural Variation on Human Disease and Evolution’ which reported on some of the lessons learnt from the most recent large-scale studies, such as HapMap3 and the 1,000 Genomes Project.

Genefficiency, OGT’s high throughput genomic services, combines industry leading platforms, expert people and unparalleled sample processing power, to rapidly deliver high quality genomic data.

“By providing high sample throughput and exacting QC standards, we enable our customers to generate high quality genomic data more efficiently, particularly for CNV,” commented Gareth Thomson, OGT’s Director of Genomic Services. “We are offering our customers the chance to sample Genefficiency for CNV analysis through our pilot study programme, which not only allows researchers to make the most of data and resources in disease research, but can also secure a credit of pilot study costs,” he added.